TERT and neoplasm: TERT is recognized by the adaptive immune system; in particular, CD4+ and CD8+ T cells recognize TERT as short peptides processed inside the cell before being exported to and presented at the cell surface by major histocompatibility complex I/II molecules, which induces an adaptive immune response associated with the inhibition of tumor growth [150–154].